We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-12.54%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$655M
AUM Growth
-$128M
Cap. Flow
-$7.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
45.75%
Holding
102
New
4
Increased
46
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$7.1M
2
CTLT
CATALENT, INC.
CTLT
+$1.46M
3
FIS icon
Fidelity National Information Services
FIS
+$1.14M
4
AAPL icon
Apple
AAPL
+$1.08M
5
PSX icon
Phillips 66
PSX
+$857K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$7.19M
2
AYX
Alteryx Inc
AYX
+$5.65M
3
MRK icon
Merck
MRK
+$3.71M
4
TECH icon
Bio-Techne
TECH
+$2.1M
5
CI icon
Cigna
CI
+$1.94M

Sector Composition

Rank Sector Weight
1 Healthcare 25.71%
2 Technology 25.24%
3 Industrials 11.67%
4 Consumer Discretionary 9.74%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
101
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-1,200
Closed -$245K
FLOW
102
DELISTED
SPX FLOW, Inc.
FLOW
– –
-5,042
Closed -$246K
1 2 3 4
5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Aristotle Atlantic Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Aristotle Atlantic Partners held 102 positions worth $655M, down 16% from $783M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Aristotle Atlantic Partners's Q1 2020 filing shows 4 new, 46 increased, 19 reduced and 10 closed positions. Its largest new stake was DexCom: 114,168 shares worth $7.69M. The largest sale was NVIDIA, an estimated $7.19M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Aristotle Atlantic Partners's largest Q1 2020 buy was DexCom: 114,168 shares worth $7.69M.
  • Aristotle Atlantic Partners added most to Fidelity National Information Services in Q1 2020, an estimated $1.14M increase.
  • Aristotle Atlantic Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $7.19M.
  • Aristotle Atlantic Partners fully exited Supernus Pharmaceuticals in Q1 2020, selling an estimated $993K.
  • Aristotle Atlantic Partners's ten largest holdings make up 46% of its $655M portfolio in Q1 2020.
  • Aristotle Atlantic Partners opened 4 new positions and closed 10 in Q1 2020.
  • Aristotle Atlantic Partners's portfolio value fell 16% quarter-over-quarter to $655M.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2020, filed 14 May 2020.